← All trials
NCT05184348
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2021
- Primary completion
- Aug 15, 2022
- Completion date
- Aug 15, 2023
- First posted
- Jan 11, 2022
- Last posted
- Feb 21, 2022
- Enrollment
- 200
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- South Valley UniversityLead sponsor
- South Valley UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.